# Defining the role of CD11c+CD88+CD317+ myeloid cells as mediators of CNS autoimmunity

> **NIH VA I01** · VA NORTH TEXAS HEALTH CARE SYSTEM · 2022 · —


## Key facts

- **NIH application ID:** 10260032
- **Project number:** 1I01BX005664-01
- **Recipient organization:** VA NORTH TEXAS HEALTH CARE SYSTEM
- **Principal Investigator:** OLAF STUVE
- **Activity code:** I01 (R01, R21, SBIR, etc.)
- **Funding institute:** VA
- **Fiscal year:** 2022
- **Award amount:** —
- **Award type:** 1
- **Project period:** 2021-10-01 → 2025-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10260032

## Citation

> US National Institutes of Health, RePORTER application 10260032, Defining the role of CD11c+CD88+CD317+ myeloid cells as mediators of CNS autoimmunity (1I01BX005664-01). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10260032. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*